Public Health & Policy >
General Professional Issues
Novartis Settles Civil and Criminal Cases for $422.5 Million
Novartis will pay a $185 million fine for promoting off-label uses of the antiepilepsy drug oxcarbazepine (Trileptal) and another $237.5 million in civil penalties to settle a suit involving Trileptal and five other drugs, the Department of Justice announced.
Oct 01, 2010